Literature DB >> 20431946

Probing the occult: testing for blood in the stools.

Denis M McCarthy.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20431946     DOI: 10.1007/s10620-010-1247-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  16 in total

1.  How much does colonoscopy reduce colon cancer mortality?

Authors:  David F Ransohoff
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

Review 2.  Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Jennifer S Lin; Elizabeth Liles; Tracy L Beil; Rongwei Fu
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

3.  Does flexible sigmoidoscopy reduce colorectal cancer incidence and mortality?

Authors:  Jason A Dominitz; Douglas J Robertson
Journal:  Gastroenterology       Date:  2009-08-28       Impact factor: 22.682

Review 4.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

5.  Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Authors:  Francis K L Chan; Jessica Y L Ching; Lawrence C T Hung; Vincent W S Wong; Vincent K S Leung; Nelson N S Kung; Aric J Hui; Justin C Y Wu; Wai K Leung; Vivian W Y Lee; Kenneth K C Lee; Yuk T Lee; James Y W Lau; Ka F To; Henry L Y Chan; S C Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs.

Authors:  Mandeep S Sawhney; Heather McDougall; Douglas B Nelson; John H Bond
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

7.  Association of colonoscopy and death from colorectal cancer.

Authors:  Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

Review 8.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

9.  Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

Authors:  Leo G van Rossum; Anne F van Rijn; Robert J Laheij; Martijn G van Oijen; Paul Fockens; Han H van Krieken; Andre L Verbeek; Jan B Jansen; Evelien Dekker
Journal:  Gastroenterology       Date:  2008-03-25       Impact factor: 22.682

10.  American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].

Authors:  Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864

View more
  1 in total

1.  Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms.

Authors:  Kaja Tikk; David Czock; Walter E Haefeli; Annette Kopp-Schneider; Hermann Brenner
Journal:  BMC Cancer       Date:  2018-09-24       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.